Category: Uncategorized

Proactive Investors Interview – Algernon Pharmaceuticals Study of Ifenprodil for the Treatment of IPF and Chronic Cough Reaches Key Stage
Streetwise Reports – Can the Psychedelic Drug DMT Take Algernon to the Next Level?
Algernon Pharmaceuticals Provides Update on Chronic Kidney Disease Research Program with NP-251
Algernon Pharmaceuticals Phase 1 DMT Stroke Study Will Start in September 2022
Business Television – Algernon Pharmaceuticals and the DMT/Stroke Clinical Program
Streetwise Live! – Algernon is Awaiting Approval for a Phase 1 DMT Human Stroke Study
Proactive Investors Interview – Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy for DMT Intellectual Property
Proactive Investors Interview – Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Stroke Study
This Pharmaceutical Company Has a Brilliant Concept – An Expert Opinion
Algernon Pharmaceuticals Ifenprodil Chronic Cough Study Receives Positive Feedback from U.S. FDA

About Us

Get the skills, guidance, and resources you need to make a big difference in your contact center operations that can lead to a big difference

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.